CTRI/2023/08/057078尚未招募3 期
An open label triple arm study to compare the effect of Niranna, Peyaya peetha sarpi and Akanthapana vamana karma in Sthula madhumeha vis a vis type 2 Diabetes mellitus - Nil
Sri Kalabyraveshwaraswamy Ayurvedic Medical College Hospital & Research centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects fit for Vamana Karma
- •Subjects fit for Rookshana karma and Snehapana
- •Subjects of either gender between the age group 18 to 60 years
- •Subjects presenting with Lakshanas of Sthula Madhumeha
- •Subjects presenting with signs and symptoms of Type II Diabetes mellitus
排除标准
- •Subjects presenting with the history of Juvenile Diabetes mellitus Gestational Diabetes mellitus Type I Diabetes mellitus and any other systemic diseases which may interfere with the course of treatment
- •Subject s presenting with the Lakshanas of Krisha Madhumeha
研究者
相似试验
尚未招募
2 期
study to evaluate the effect of application of hot metal(agnikarma) and application of alkali (palasha kshara karma) in fissure.CTRI/2021/03/031692Dr Santoshkumar
尚未招募
2 期
Clinical Study to Compare The Effect Of Aragvadhadi Udvartana(Medicated powder massage) followed by Vamana Karma( therapeutic vimiting)and Aragvadhadi Takraparisheka(Pouring of medicated buttermilk)followed by Vamana karma(therapeutic emesis) in Ekakushta(Psoriasis)CTRI/2021/02/031014Dr Muktha Bharadwaj K A
尚未招募
2 期
clinical study to compare the effect of udwartana(medicated powder massage ), Virechana (purgation therapy) and Udwartana(medicated powder massage), Virechana karma(puragation therapy) with internallty ayaskruti and vidangadi churnaCTRI/2021/02/031156Dr Manal VM
招募中
4 期
Seronegatives And Metabolic Abnormalities Protocol 2 (SAMA 002)HIVLipid metabolismGlucose metabolismMetabolic abnormalityLipodystrophyInfection - Acquired immune deficiency syndrome (AIDS / HIV)Cardiovascular - Other cardiovascular diseasesCardiovascular diseaseACTRN12605000661673The University of New South Wales50
进行中（未招募）
1 期
Open-label, multi-centre study to compare the effectiveness of QvarTM Autohaler therapy with conventional therapy (similar doses) in children with stable asthmaChildren aged 7 - 12 with stable mild persistent to moderate persistent asthma (according to the GINA classification)Classification code 10003553EUCTR2004-001928-20-BECB Pharma Belgium300